NCT04888858

Brief Summary

There are multiple factors that determine progress of normal vaginal delivery. Frequency, duration and strength of uterine contractions are important for progress throughout labor, and abdominal wall muscle contractions contribute to progress during the final stage. Epidural analgesia helps to alleviate the pain associated with uterine contractions, this however this comes at the expense of prolonging labor by reducing the strength of abdominal wall muscle contractions. The purpose of this prospective study is to quantify how much epidurals decrease the strength of abdominal wall contractions. Intraabdominal pressure will be used as surrogate to strength of abdominal wall contractions, and it will be measured via a foley catheter inserted into the urinary bladder as part of standard procedure for patients receiving labor epidurals. We will compare the change in intraabdominal pressure when patients perform forceful abdominal contractions (valsalva maneuvers) prior to and during epidural analgesia. This will lay the foundation for a future study in which we plan to compare the effects of different epidural analgesia types and concentrations on abdominal wall muscle contractions.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Nov 2020

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 2, 2020

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

May 6, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 17, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 2, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 2, 2022

Completed
Last Updated

September 25, 2023

Status Verified

September 1, 2023

Enrollment Period

1.7 years

First QC Date

May 6, 2021

Last Update Submit

September 21, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • The change in intraabdominal pressure (surrogate of maternal force)

    The change in intraabdominal pressure will be measured prior to receiving epidural analgesia, and again at 1 and 2 hours following administration. The change observed before and after will be compared to quantify the decreased change following epidural administration.

    2 hours following initial administration of labor epidural

Secondary Outcomes (3)

  • Mode of delivery

    Up to 72 hours after initial administration of labor epidural

  • Duration of second stage of labor

    Up to 72 hours after initial administration of labor epidural

  • Apgar scores

    Up to 72 hours after initial administration of labor epidural

Study Arms (1)

Epidural Analgesia

EXPERIMENTAL

All subjects will be given epidural analgesia to treat their labor pain. As part of standard protocol for all patients who receive a labor epidural, the epidural will then be tested using 3ml of 1.5% lidocaine and 1:200,000 epinephrine test solution, and the epidural catheter will then be loaded with 10ml of 0.125% bupivacaine solution. The epidural catheter will then be connected to a programmed intermittent epidural bolus pump which will administer 5ml of a 0.125% bupivacaine/2mcg fentanyl solution every 30minutes. The first dose will be given following 30minutes after the loading dose. 30 minutes after loading the loading dose and after the first pump dose has been given, we will assess the VAS pain scores and the level of the analgesic based on decreased sensation to ice.

Drug: Epidural analgesia (0.125% bupivacaine/2mcg fentanyl solution)

Interventions

As part of standard protocol for all patients who receive a labor epidural, the epidural will then be tested using 3ml of 1.5% lidocaine and 1:200,000 epinephrine test solution, and the epidural catheter will then be loaded with 10ml of 0.125% bupivacaine solution. The epidural catheter will then be connected to a programmed intermittent epidural bolus pump which will administer 5ml of a 0.125% bupivacaine/2mcg fentanyl solution every 30minutes. The first dose will be given following 30minutes after the loading dose. 30 minutes after loading the loading dose and after the first pump dose has been given, we will assess the VAS pain scores and the level of the analgesic based on decreased sensation to ice.

Epidural Analgesia

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPatients must be healthy pregnant women that have reached the decision to receive epidural analgesia for their labor.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult (18 years and older)
  • Pregnant women in their third trimester
  • Able to read and speak English
  • Capacity to consent to participate
  • Receiving a labor epidural catheter during their labor and delivery at HFH-Main

You may not qualify if:

  • Severe cardiac disease
  • People who are unable/medically recommended not to perform valsalva maneuvers
  • People who are not undergoing labor epidural analgesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Henry Ford Hospital

Detroit, Michigan, 48202, United States

Location

MeSH Terms

Conditions

Labor PainAgnosia

Interventions

Analgesia, Epidural

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Intervention Hierarchy (Ancestors)

AnalgesiaAnesthesia and Analgesia
0

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: The force of the maternal push when performing Valsalva maneuver will be compared before and after administration of epidural analgesia.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Staff Anesthesiologist

Study Record Dates

First Submitted

May 6, 2021

First Posted

May 17, 2021

Study Start

November 2, 2020

Primary Completion

July 2, 2022

Study Completion

July 2, 2022

Last Updated

September 25, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

There is not a plan to share individual participant data with other researchers.

Locations